Association of matrix metalloproteinase-1 and -3 promoter polymorphisms with clinical subsets of Norwegian primary sclerosing cholangitis patients

Journal of Hepatology

Volumn 41, Issue 2, 2004, Pages 209-214

  Wiencke, Kristine ^a   Louka, Andrew Sverre ^a   Spurkland, Anne ^b   Vatn, Morten ^a   Schrumpf, Erik ^a   Boberg, Kirsten Muri ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

Candidate genes; Cholangiocarcinoma; Genetic association; Inflammatory bowel disease; Liver fibrosis; Metalloproteinase; MMP 1; MMP 3; Primary sclerosing cholangitis

Indexed keywords

INTERSTITIAL COLLAGENASE; STROMELYSIN;

ADOLESCENT; ADULT; AGED; ARTICLE; BILE DUCT CARCINOMA; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NORWAY; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; SCHOOL CHILD; SCLEROSING CHOLANGITIS; STATISTICAL SIGNIFICANCE; ULCERATIVE COLITIS;

ADOLESCENT; ADULT; AGED; ALLELES; CHILD; CHOLANGITIS, SCLEROSING; CHROMOSOME MAPPING; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HLA-DR3 ANTIGEN; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; MATRIX METALLOPROTEINASE 1; MATRIX METALLOPROTEINASE 3; MIDDLE AGED; NORWAY; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS);

EID: 4444228642     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2004.04.024     Document Type: Article

References (29)

1. Chapman R.W., Arborgh B.A., Rhodes J.M., Summerfield J.A., Dick R., Scheuer P.J., Sherlock S. Primary sclerosing cholangitis: a review of its clinical features, cholangiography, and hepatic histology. Gut. 21:1980;870-877
2. Fausa O., Schrumpf E., Elgjo K. Relationship of inflammatory bowel disease and primary sclerosing cholangitis.(Review). Semin Liver Dis. 11:1991;31-39
3. Bergquist A., Ekbom A., Olsson R., Kornfeldt D., Lööf L., Danielsson A., et al. Hepatic and extrahepatic malignancies in primary sclerosing cholangitis. J Hepatol. 36:2002;321-327
4. Boberg K.M., Lundin K.E., Schrumpf E. Etiology and pathogenesis in primary sclerosing cholangitis. Scand J Gastroenterol. 204:1994;47-58
5. Schrumpf E., Fausa O., Förre Ö., Dobloug J.H., Ritland S., Thorsby E. HLA antigens and immunoregulatory T cells in ulcerative colitis associated with hepatobiliary disease. Scand J Gastroenterol. 17:1982;187-191
6. Donaldson P.T., Farrant J.M., Wilkinson M.L., Hayllar K., Portmann B.C., Williams R. Dual association of HLA DR2 and DR3 with primary sclerosing cholangitis. Hepatology. 13:1991;129-133
7. Spurkland A., Saarinen S., Boberg K.M., Mitchell S., Broome U., Caballeria L., et al. HLA class II haplotypes in primary sclerosing cholangitis patients from five European populations. Tissue Antigens. 53:1999;459-469
8. Donaldson P.T., Norris S. Immunogenetics in PSC. Best Pract Res Clin Gastroenterol. 15:2001;611-627
9. von Lampe B., Barthel B., Coupland S.E., Riecken E.O., Rosewicz S. Differential expression of matrix metalloproteinases and their tissue inhibitors in colon mucosa of patients with inflammatory bowel disease. Gut. 47:2000;63-73
10. Arthur M.J. Fibrogenesis II. Metalloproteinases and their inhibitors in liver fibrosis. Am J Physiol Gastrointest Liver Physiol. 279:2000;G245-G249
11. Formstone C.J., Byrd P.J., Ambrose H.J., Riley J.H., Hernandez D., McConville C.M., Taylor A.M. The order and orientation of a cluster of metalloproteinase genes, stromelysin 2, collagenase, and stromelysin, together with D11S385, on chromosome 11q22-q23. Genomics. 16:1993;289-291
12. Rutter J.L., Mitchell T.I., Buttice G., Meyers J., Gusella J.F., Ozelius L.J., Brinckerhoff C.E. A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter creates an Ets binding site and augments transcription. Cancer Res. 58:1998;5321-5325
13. Ye S., Eriksson P., Hamsten A., Kurkinen M., Humphries S.E., Henney A.M. Progression of coronary atherosclerosis is associated with a common genetic variant of the human stromelysin-1 promoter which results in reduced gene expression. J Biol Chem. 271:1996;13055-13060
14. McCawley L.J., Matrisian L.M. Matrix metalloproteinases: multifunctional contributors to tumor progression. Mol Med Today. 6:2000;149-156
15. Ghilardi G., Biondi M.L., Mangoni J., Leviti S., DeMonti M., Guagnellini E., Scorza R. Matrix metalloproteinase-1 promoter polymorphism 1G/2G is correlated with colorectal cancer invasiveness. Clin Cancer Res. 7:2001;2344-2346
16. Monvoisin A., Bisson C., Si-Tayeb K., Balabaud C., Desmouliere A., Rosenbaum J. Involvement of matrix metalloproteinase type-3 in hepatocyte growth factor-induced invasion of human hepatocellular carcinoma cells. Int J Cancer. 97:2002;157-162
17. Moum B., Ekbom A., Vatn M.H., Aadland E., Sauar J., Lygren I., et al. Clinical course during the 1st year after diagnosis in ulcerative colitis and Crohn's disease. Results of a large, prospective population-based study in southeastern Norway, 1990-93. Scand J Gastroenterol. 32:1997;1005-1012
18. Louka A.S., Stensby E.K., Ek J., Gudjonsdottir A.H., Ascher H., Sollid L.M. Coeliac disease candidate genes: no association with functional polymorphisms in matrix metalloproteinase 1 and 3 gene promoters. Scand J Gastroenterol. 37:2002;931-935
19. Schneider S, Roessli D, Excoffier L. Arlequin. (2.000). 2000. Genetics and Biometry Laboratory, University of Geneva, Switzerland.
20. Klitz W., Stephens J.C., Grote M., Carrington M. Discordant patterns of linkage disequilibrium of the peptide-transporter loci within the HLA class II region. Am J Hum Genet. 57:1995;1436-1444
21. Gomes I., Collins A., Lonjou C., Thomas N.S., Wilkinson J., Watson M., Morton N. Hardy-Weinberg quality control. Ann Hum Genet. 63:1999;535-538
22. Satsangi J., Chapman R.W., Haldar N., Donaldson P., Mitchell S., Simmons J., et al. A functional polymorphism of the stromelysin gene (MMP-3) influences susceptibility to primary sclerosing cholangitis. Gastroenterology. 121:2001;124-130
23. Selmi C., Zuin M., Meda F., Podda M., Biondi M.L., Cecchini F. Common variants of the matrix metalloproteinase-3 (stromelysin) gene promoter in primary biliary cirrhosis. Gastroenterology. 122:2002;247-248
24. Wiencke K., Spurkland A., Schrumpf E., Boberg K.M. Primary sclerosing cholangitis is associated to an extended B8-DR3 haplotype including particular MICA and MICB alleles. Hepatology. 34:2001;625-630
25. Lee Y.M., Kaplan M.M. Primary sclerosing cholangitis. N Engl J Med. 332:1995;924-933
26. Boberg K.M., Bergquist A., Mitchell S., Pares A., Rosina F., Broome U., et al. Cholangiocarcinoma in primary sclerosing cholangitis: risk factors and clinical presentation. Scand J Gastroenterol. 37:2002;1205-1211
27. Bonen D.K., Cho J.H. The genetics of inflammatory bowel disease. Gastroenterology. 124:2003;521-536
28. Pender S.L., Tickle S.P., Docherty A.J., Howie D., Wathen N.C., MacDonald T.T. A major role for matrix metalloproteinases in T cell injury in the gut. J Immunol. 158:1997;1582-1590
29. Cardon L.R., Bell J.I. Association study designs for complex diseases. Nat Rev Genet. 2:2001;91-99